Pricing Log in Create free account

Adicet Bio, Inc. (ACET) vs iBio, Inc. (IBIO)

Adicet Bio, Inc. and iBio, Inc. are both Biotechnology companies. Adicet Bio, Inc. and iBio, Inc. are of similar size ($48.1M and $47.6M). Adicet Bio, Inc. grew revenue faster over the last twelve months: 224.6% against −66.6%. Across the 16 metrics below, iBio, Inc. leads on 11 and Adicet Bio, Inc. on 5.

Valuation

Metric ACET IBIO Biotechnology median
P/E n/m n/m 8.50
P/S 1.27 118.71 9.71
P/B 0.41 0.93 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.67 0.19 0.64
EV/Sales (1.77) (9.70) 9.21
Earnings yield (250.55%) (44.16%) (33.15%)
Free cash flow yield (173.02%) (30.24%) (25.50%)

Profitability

Metric ACET IBIO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (78.08%) (65.70%) (56.36%)
Return on assets (63.62%) (54.04%) (48.04%)
Return on invested capital (2,518.16%) 0.00% 0.00%

Growth

Metric ACET IBIO Biotechnology median
Revenue growth (TTM) 224.62% (66.55%) 6.02%
EPS growth (last fiscal year) 20.35% 81.71% 30.26%
Revenue growth, 5-year CAGR 6.90% (42.83%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACET IBIO Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 6.71 7.85 4.72
Net debt to EBITDA 1.32 2.57 0.96

Dividend

Metric ACET IBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACET IBIO Biotechnology median
Market cap 48.12m 47.63m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack